Your non-HDL cholesterol result refers to your total cholesterol value minus your HDL cholesterol. Your lipid panel results normally include four numbers:
- low-density lipoprotein (LDL) cholesterol;
- high-density lipoprotein (HDL) cholesterol;
- triglycerides; and
- total cholesterol.
Some researchers believe that measuring your non-HDL cholesterol levels gives a better assessment of the risk for heart disease than measuring only LDL. This is especially true if you have high triglycerides. Your non-HDL cholesterol level is found by subtracting your HDL cholesterol from your total cholesterol.
Although you might assume total cholesterol is simply the sum of your LDL and HDL, it also includes very-low-density lipoprotein (VLDL). These particles carry triglycerides to tissues and eventually become LDL. Like LDL, it also causes cholesterol to build up on the inside of arteries, creating artery-clogging plaque. Both are considered undesirable, so the higher your LDL and VLDL values, the higher your risk of heart disease.
Achieved non-HDL cholesterol levels seem more closely associated with coronary atheroma progression than LDL cholesterol.
Why Do Doctors Still Rely On LDL Instead Of Non-HDL Cholesterol? (http://www.cardiobrief.org/2017/10/15/why-do-doctors-still-rely-on-ldl-instead-of-non-hdl-cholesterol/)
Non-HDL Cholesterol and Triglycerides, Implications for Coronary Atheroma Progression and Clinical Events, http://atvb.ahajournals.org/content/36/11/2220
- Reduction in total calories, especially saturated and trans fatty acids, in combination with exercise is recommended.
- Reducing sugar and carbohydrate consumption is often very effective in lowering triglycerides and non-HDL-C, particularly in patients with abdominal obesity or the metabolic syndrome.
- Moderate physical activity can help raise HDL-C and lower non-HDL-C.
- Quitting smoking will improve your HDL-C and reduce non-HDL-C. Several studies have shown that male and female smokers have significantly lower HDL-C levels than non-smokers.
- Medical therapy. This would include the use of a statin drug to serve as the foundation for LDL-C lowering followed by a second treatment to bring non-HDL-C to within the target range.
$79 per year
$6.60 per month billed annually
$79 per year
Save time on interpreting lab results with the largest database of biomarkers online. In-depth research on any test at your fingertips, all stored and tracked in one place.Learn More